ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1479

Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study

Jung Su Eun1, Eun Song Lee2, Jong Wan Kang1, Na Ri Kim1, Ji Hun Kim1, Jin Young Kang1, Eon Jeong Nam3 and Young Mo Kang1, 1Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea, The Republic of, 2Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular disease (CVD) and premature mortality, compared to the general population. Inflammatory burden and conventional cardiovascular (CV) risk factors contribute to the development of carotid atherosclerosis in patients with RA. We evaluated the effects of RA on the occurrence of CVD and mortality in a prospective study of an Asian population.

Methods:  A total of 369 patients with RA and 160 healthy controls were followed up for 5 years or until deaths in a prospective KARRA cohort study (412 patients and 221 controls at baseline). To detect the presence and progression of carotid atherosclerosis, we performed carotid ultrasound at baseline and 5-year. We analyzed the incidence of CVD, conventional CV risk factors, RA disease activity and severity markers, medication histories, mortality rate, and causes of death.

Results:  During 5-year follow-up period, the mortality rate was 5.8% (24/412) in RA patients and 0% in healthy controls (p<0.001), while the incidence of CVD were 6.1% (25/412) in RA patients and 0.5% (1/221) in healthy controls (p<0.001). Among CVD in RA patients, cerebrovascular accident (CVA) and cardiovascular event (CVE) were 8 (32%) and 17 (68%) events, respectively. Major causes of death included infection (11/24, 45.8%), CVD (6/24, 25%), and others (7/24, 29.2%). The mean age, presence and number of carotid plaques, functional class, modified Korean version of the HAQ (mKHAQ), tender joint count (TJC), swollen joint count (SJC), ESR and CRP, and conventional CV risk factors at baseline were significantly associated with mortality among RA patients. Multivariate logistic regression analysis showed that the presence of carotid plaque (OR 5.32 [95% CI 1.09-25.99; P = 0.039]), mKHAQ (OR 1.07 [95% CI 1.02-1.13; P = 0.007]), and ESR (OR 1.04 [95% CI 1.02-1.06; P < 0.001]) at baseline were independent risk factor for mortality of RA patients. In contrast, factors associated with new-onset CVD included the mean age, presence and number of carotid plaques, peak CRP, and conventional CV risk factors at baseline. Carotid plaque (OR 7.86 [95% CI 2.14-28.83; P = 0.002]) and two or more CV risk factors (OR 4.77 [95% CI 1.07-21.23; P = 0.040]) at baseline were independent predictive factors for new-onset CVD of RA patients in a multivariate logistic regression analysis.

Conclusion:  This prospective study shows that a common risk factor for CVD and mortality is carotid plaque which is determined by disease activity and CV risk factors. While disease activity of RA is a critical determinant for the mortality, the development of CVD depends on conventional CV risk factors.


Disclosure: J. S. Eun, None; E. S. Lee, None; J. W. Kang, None; N. R. Kim, None; J. H. Kim, None; J. Y. Kang, None; E. J. Nam, None; Y. M. Kang, None.

To cite this abstract in AMA style:

Eun JS, Lee ES, Kang JW, Kim NR, Kim JH, Kang JY, Nam EJ, Kang YM. Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-diseases-and-mortality-are-independently-influenced-by-carotid-plaque-presence-in-rheumatoid-arthritis-the-5-year-prospective-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-diseases-and-mortality-are-independently-influenced-by-carotid-plaque-presence-in-rheumatoid-arthritis-the-5-year-prospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology